silver has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Salam, S; Ali, BH; Ferdous, Z; Greish, YE; Nemmar, A | 1 |
| Epinette, WW; Nasser, WK; Rich, LL | 1 |
2 other study(ies) available for silver and Cardiac Diseases
| Article | Year |
|---|---|
Pulmonary exposure to silver nanoparticles impairs cardiovascular homeostasis: Effects of coating, dose and time.
Topics: Animals; Apoptosis; Blood Coagulation; Cardiotoxicity; Citric Acid; DNA Damage; Dose-Response Relationship, Drug; Female; Heart Diseases; Inflammation Mediators; Inhalation Exposure; Intracranial Thrombosis; Male; Metal Nanoparticles; Mice, Inbred BALB C; Myocytes, Cardiac; Oxidative Stress; Platelet Aggregation; Povidone; Silver; Surface Properties; Time Factors | 2019 |
Argyria presenting as cyanotic heart disease.
Topics: Aged; Argyria; Cyanosis; Diagnosis, Differential; Heart Diseases; Humans; Iodides; Male; Silver; Skin | 1972 |